Mirum Pharmaceuticals Correlations
MIRM Stock | USD 50.27 0.20 0.40% |
The current 90-days correlation between Mirum Pharmaceuticals and Glacier Bancorp is -0.08 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mirum Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mirum Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Mirum Pharmaceuticals Correlation With Market
Very weak diversification
The correlation between Mirum Pharmaceuticals and DJI is 0.54 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mirum Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Mirum Stock
0.65 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
0.78 | NVS | Novartis AG ADR | PairCorr |
0.87 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.88 | GRFS | Grifols SA ADR | PairCorr |
0.62 | PPERF | Bank Mandiri Persero | PairCorr |
0.84 | TLK | Telkom Indonesia Tbk | PairCorr |
0.74 | EC | Ecopetrol SA ADR | PairCorr |
0.67 | CIO-PA | City Office REIT | PairCorr |
0.61 | VCIGF | Vitreous Glass | PairCorr |
0.91 | VST | Vistra Energy Corp | PairCorr |
0.74 | SPNS | Sapiens International | PairCorr |
0.87 | STRT | Strattec Security | PairCorr |
0.82 | EBS | Emergent Biosolutions | PairCorr |
0.81 | AA | Alcoa Corp Earnings Call This Week | PairCorr |
0.83 | GE | GE Aerospace | PairCorr |
Moving against Mirum Stock
0.37 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.36 | OGN | Organon | PairCorr |
0.31 | XNCR | Xencor Inc | PairCorr |
0.65 | MCD | McDonalds | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Mirum Stock performing well and Mirum Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mirum Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CIO-P-A | 1.10 | 0.08 | 0.00 | 0.99 | 1.75 | 2.28 | 11.85 | |||
GBCI | 1.90 | 0.10 | 0.01 | (1.67) | 2.75 | 3.28 | 17.00 | |||
JBGS | 1.74 | 0.14 | 0.03 | (1.03) | 1.90 | 4.39 | 9.22 | |||
HTB | 1.26 | 0.13 | 0.06 | 0.25 | 1.69 | 2.83 | 10.93 | |||
IREN | 3.76 | 1.38 | 0.31 | 0.93 | 3.67 | 8.94 | 18.27 | |||
HIW | 1.35 | 0.02 | 0.01 | 0.10 | 1.88 | 2.57 | 9.44 | |||
PFLT | 1.23 | (0.02) | 0.00 | 0.17 | 0.00 | 2.05 | 10.23 | |||
UVSP | 1.61 | 0.18 | 0.05 | 1.83 | 2.16 | 3.68 | 10.04 |
Mirum Pharmaceuticals Corporate Management
Peter MBA | Chief Officer | Profile | |
Ian Clements | Chief Officer | Profile | |
MSC MBA | Chief Officer | Profile | |
Douglas JD | Chief Officer | Profile | |
Jolanda Howe | Senior Controller | Profile | |
Eric MBA | Chief Officer | Profile |